Page last updated: 2024-09-04

resiquimod and Pleural Effusion, Malignant

resiquimod has been researched along with Pleural Effusion, Malignant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gu, FF; Hu, Y; Li, M; Liang, JY; Liu, L; Liu, YY; Wang, Y; Wu, JJ; Zhang, K; Zhang, YA	1

Other Studies

1 other study(ies) available for resiquimod and Pleural Effusion, Malignant

Article	Year
Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation. Cancer immunology, immunotherapy : CII, 2020, Volume: 69, Issue:5 Topics: Carcinoma, Non-Small-Cell Lung; Cell Communication; Cell Differentiation; Dendritic Cells; Humans; Imidazoles; Lipopolysaccharides; Lung Neoplasms; Lymphocyte Activation; Macrophages; Phagocytosis; Pleural Effusion, Malignant; Primary Cell Culture; Th1 Cells; Toll-Like Receptors; Tumor Cells, Cultured	2020

Article

Year

Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation.

Cancer immunology, immunotherapy : CII, 2020, Volume: 69, Issue:5

Topics: Carcinoma, Non-Small-Cell Lung; Cell Communication; Cell Differentiation; Dendritic Cells; Humans; Imidazoles; Lipopolysaccharides; Lung Neoplasms; Lymphocyte Activation; Macrophages; Phagocytosis; Pleural Effusion, Malignant; Primary Cell Culture; Th1 Cells; Toll-Like Receptors; Tumor Cells, Cultured

2020